Literature DB >> 15365083

Exemestane following tamoxifen in postmenopausal women with primary breast cancer.

Henning T Mouridsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15365083     DOI： 10.1200/JCO.2004.99.115

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

1.  Emerging principles for the development of resistance to antihormonal therapy: implications for the clinical utility of fulvestrant.

Authors:  Eric A Ariazi; Joan S Lewis-Wambi; Shaun D Gill; Jennifer R Pyle; Jennifer L Ariazi; Helen R Kim; Catherine G N Sharma; Fernando Cordera; Heather A Shupp; Tianyu Li; V Craig Jordan
Journal:  J Steroid Biochem Mol Biol       Date:  2006-11-07       Impact factor: 4.292
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.